HS 9401-61-10-90 – Other

Tariff data as of T2026-2, effective Sept 1, 2026, last verified Oct 21, 2026

US-origin goods: 25% surtax (United States Surtax Order (2026), SOR/2026-186, in force Sep 8, 2026)

Seats (other than those of heading 94.02), whether or not convertible into beds, and parts thereof. › Upholstered › Other

MFN duty rate

9.5 %

GST

5%

Unit of measure

-

Other

Estimate duty & taxes · Get classification help

Preferential tariff rates

• Panama (PAT): Free
• Honduras (HNT): Free
• CPTPP: Free
• MXT/CUSMA (Mexico): Free
• Iceland: Free
• UK: Free
• Colombia: Free
• CETA: Free
• Korea: Free
• Peru: Free
• Switzerland–Liechtenstein (SLT): Free
• Commonwealth Caribbean Countries Tariff (CCCT): Free
• GPT: 6%
• UST/CUSMA (US): Free
• Chile: Free
• Ukraine: Free
• LDCT: Free
• Norway (NT): Free
• CPTPP – United Kingdom (CPUKT): Free
• Jordan (JT): Free
• Costa Rica (CRT): Free
• Israel (CIAT): Free

Preference requires qualifying origin and origin proof or certification.

Frequently asked questions

What is the MFN duty on Other (HS 9401-61-10-90)?

The T2026-2 MFN rate for tariff item 9401.61.10 is 9.5%. Specific or compound rates require manual calculation. Classification and origin must be verified with CBSA.

What is the duty on HS 9401-61-10-90 from the US?

Qualifying US-origin goods with origin proof use UST/CUSMA at Free. US-origin goods: 25% surtax (United States Surtax Order (2026), SOR/2026-186, in force Sep 8, 2026) GST/HST and any applicable personal-import provincial tax are additional.

Which trade agreement rates apply to HS 9401-61-10-90?

Panama (PAT): Free; Honduras (HNT): Free; CPTPP: Free; MXT/CUSMA (Mexico): Free; Iceland: Free; UK: Free; Colombia: Free; CETA: Free; Korea: Free; Peru: Free; Switzerland–Liechtenstein (SLT): Free; Commonwealth Caribbean Countries Tariff (CCCT): Free; GPT: 6%; UST/CUSMA (US): Free; Chile: Free; Ukraine: Free; LDCT: Free; Norway (NT): Free; CPTPP – United Kingdom (CPUKT): Free; Jordan (JT): Free; Costa Rica (CRT): Free; Israel (CIAT): Free. Preferential treatment requires qualifying origin and certification. Rates are informational; CBSA is authoritative.